Why the study?
The added value of venous outflow imaging beyond arterial collaterals and perfusion measures in acute ischemic stroke remains uncertain. More than a dozen CT and MR measures have been proposed, differing in what they measure, evidence maturity, and readiness for clinical reporting.
This ASFNR State of Practice statement establishes that CT and MRI venous outflow markers in acute ischemic stroke serve as descriptive prognostic measures rather than treatment-selection criteria, with the cortical vein opacification score (COVES) having the most mature CTA evidence.
Answers are grounded in this paper and cite their sources.
Avoid venous outflow markers for treatment selection in acute ischemic stroke; extends consensus on COVES as leading prognostic CTA marker.
BACKGROUND: Venous outflow (VO) imaging describes the egress limb of the cerebral collateral circulation and has been associated with outcome in acute ischemic stroke; its added value beyond arterial collaterals and perfusion measures remains uncertain. More than a dozen VO measures have been proposed on CT and MR techniques used in acute stroke, spanning three physical signals: venous opacification, venous transit and venous oxygenation. They differ in what they measure, in evidence maturity and in readiness for reporting. METHODS: A writing group reviewed the peer-reviewed studies of cerebral venous drainage measures in acute ischemic stroke. The scope is CT and MRI obtained during routine acute stroke evaluation, excluding measures that require catheter angiography or ultrasound. We describe each measure's acquisition, definition, evidence and technical limitations, and propose a reporting framework based on these features. KEY MESSAGE: VO markers are descriptive prognostic measures, not treatment-selection criteria. The cortical vein opacification score (COVES) has the most mature CTA evidence and may be considered when venous timing is adequate, though meta-analyses support an association rather than a threshold; comprehensive venous outflow (CVO) adds the internal cerebral vein. Prolonged venous transit (PVT) adds a temporal dimension read from perfusion, but remains investigational, as do the composite arterial-venous scores, quantitative venous timing and oxygen extraction fraction mapping. Susceptibility signs index deoxygenation and venous blood volume, not drainage. Reporting should name the technique and describe opacification, transit or oxygenation findings in their own terms. The evidence base is predominantly anterior-circulation large-vessel occlusion imaged before thrombectomy.
No takes yet. Share an insight, caveat, or question.
Salim et al. (2026) conducted a review in Acute ischemic stroke. Venous outflow (VO) imaging (CT and MRI) was evaluated. Venous outflow imaging markers in acute ischemic stroke are descriptive prognostic measures rather than treatment-selection criteria, with cortical vein opacification score having the most mature CTA evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: